3/12
03:50 pm
incy
Incyte (INCY) Up 2.6% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
Low
Report
Incyte (INCY) Up 2.6% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
3/8
09:01 am
incy
Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura®) in Patients with Prurigo Nodularis (PN) at 2025 American Academy of Dermatology Annual Meeting
Low
Report
Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura®) in Patients with Prurigo Nodularis (PN) at 2025 American Academy of Dermatology Annual Meeting
3/7
04:30 pm
incy
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/4
11:24 am
incy
Janus Kinase (JAK) Inhibitor Pipeline Market Insights Report 2025: Comprehensive Review of 50+ Companies and Respective 55+ Drugs [Yahoo! Finance]
Low
Report
Janus Kinase (JAK) Inhibitor Pipeline Market Insights Report 2025: Comprehensive Review of 50+ Companies and Respective 55+ Drugs [Yahoo! Finance]
3/3
03:18 pm
incy
JAK Inhibitors Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight [Yahoo! Finance]
Low
Report
JAK Inhibitors Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight [Yahoo! Finance]
2/28
02:21 pm
incy
OPZELURA Continues to Revolutionize Dermatology Market with Strong Market Uptake | DelveInsight [Yahoo! Finance]
Low
Report
OPZELURA Continues to Revolutionize Dermatology Market with Strong Market Uptake | DelveInsight [Yahoo! Finance]
2/28
10:03 am
incy
Incyte to Unveil New Data from its Dermatology Portfolio at 2025 American Academy of Dermatology (AAD) Annual Meeting [Yahoo! Finance]
Low
Report
Incyte to Unveil New Data from its Dermatology Portfolio at 2025 American Academy of Dermatology (AAD) Annual Meeting [Yahoo! Finance]
2/28
09:30 am
incy
Incyte to Unveil New Data from its Dermatology Portfolio at 2025 American Academy of Dermatology (AAD) Annual Meeting
Low
Report
Incyte to Unveil New Data from its Dermatology Portfolio at 2025 American Academy of Dermatology (AAD) Annual Meeting
2/20
09:03 am
incy
Incyte and Genesis to collaborate on developing small molecule medicines using AI research [Seeking Alpha]
Low
Report
Incyte and Genesis to collaborate on developing small molecule medicines using AI research [Seeking Alpha]
2/20
08:16 am
incy
Incyte and Genesis Therapeutics Announce Strategic AI-focused Research Collaboration [Yahoo! Finance]
Low
Report
Incyte and Genesis Therapeutics Announce Strategic AI-focused Research Collaboration [Yahoo! Finance]
2/20
08:00 am
incy
Incyte and Genesis Therapeutics Announce Strategic AI-focused Research Collaboration
Low
Report
Incyte and Genesis Therapeutics Announce Strategic AI-focused Research Collaboration
2/18
08:32 am
incy
Incyte to Present at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Incyte to Present at Upcoming Investor Conferences [Yahoo! Finance]
2/18
08:00 am
incy
Incyte to Present at Upcoming Investor Conferences
Low
Report
Incyte to Present at Upcoming Investor Conferences
2/17
01:34 pm
incy
Polycythemia Vera Market Insight, Epidemiology and Market Forecast, 2034: JAKAFI & BESREMi Lead Polycythemia Vera Market, But New Therapies Poised to Disrupt by 2034 [Yahoo! Finance]
Low
Report
Polycythemia Vera Market Insight, Epidemiology and Market Forecast, 2034: JAKAFI & BESREMi Lead Polycythemia Vera Market, But New Therapies Poised to Disrupt by 2034 [Yahoo! Finance]
2/12
01:32 am
incy
Incyte Co. (NASDAQ: INCY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Medium
Report
Incyte Co. (NASDAQ: INCY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
2/11
10:59 am
incy
Incyte Co. (NASDAQ: INCY) had its "market perform" rating re-affirmed by analysts at JMP Securities.
Low
Report
Incyte Co. (NASDAQ: INCY) had its "market perform" rating re-affirmed by analysts at JMP Securities.
2/11
09:08 am
incy
Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Royal Bank of Canada from $70.00 to $68.00. They now have a "sector perform" rating on the stock.
Low
Report
Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Royal Bank of Canada from $70.00 to $68.00. They now have a "sector perform" rating on the stock.
2/11
08:09 am
incy
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at Stifel Nicolaus from $75.00 to $77.00. They now have a "hold" rating on the stock.
Low
Report
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at Stifel Nicolaus from $75.00 to $77.00. They now have a "hold" rating on the stock.
2/11
08:09 am
incy
Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Citigroup Inc. from $97.00 to $88.00. They now have a "buy" rating on the stock.
Low
Report
Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Citigroup Inc. from $97.00 to $88.00. They now have a "buy" rating on the stock.
2/11
05:57 am
incy
Incyte Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
Incyte Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
2/11
02:29 am
incy
Incyte Corp (INCY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook [Yahoo! Finance]
Low
Report
Incyte Corp (INCY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook [Yahoo! Finance]
2/10
05:14 pm
incy
Incyte Reports 2024 Financial Results and Outlines 2025 Projections [Yahoo! Finance]
Low
Report
Incyte Reports 2024 Financial Results and Outlines 2025 Projections [Yahoo! Finance]
2/10
03:30 pm
incy
Incyte Stock Sinks as Sales Forecast for Key Drugs Falls Short [Yahoo! Finance]
Low
Report
Incyte Stock Sinks as Sales Forecast for Key Drugs Falls Short [Yahoo! Finance]
2/10
03:21 pm
incy
Why Incyte (INCY) Shares Are Plunging Today [Yahoo! Finance]
Low
Report
Why Incyte (INCY) Shares Are Plunging Today [Yahoo! Finance]
2/10
12:36 pm
incy
INCY's Q4 Results in Detail [Yahoo! Finance]
Low
Report
INCY's Q4 Results in Detail [Yahoo! Finance]